ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

7,195Medicare Part D Prescriptions Filled, Including Refills

Rank: 160 out of 387

$406K Total Retail Price of All Prescriptions

Rank: 182 out of 387

322 Patients Receiving at Least One Drug in Part D
82%Patients 65 Years and Older
64% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Oklahoma
Lower avg

Schedule Two
Controlled Substances

9% of this provider’s 322 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

19% of this provider’s 322 patients filled at least one prescription for a schedule three drug, compared to an average of 16%.

Risky Drugs to Seniors

1% of this provider’s 6,249 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$56 was the average price of a prescription from this provider, compared to $64 among peers.

Prescriptions per Patient

22 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Oklahoma
LISINOPRIL 337 293 1 3
LEVOTHYROXINE SODIUM 317 289 2 2
AMLODIPINE BESYLATE 249 221 3 6
METOPROLOL TARTRATE 227 189 4 11
FUROSEMIDE 226 206 5 7
SIMVASTATIN 212 204 6 5
OMEPRAZOLE 203 163 7 4
DONEPEZIL HCL 201 201 8 27
HYDROCODONE-ACETAMINOPHEN 161 123 S3 9 1
NAMENDA 140 140 10 35
FAMOTIDINE 124 98 11 78
CITALOPRAM HBR 123 121 12 19
WARFARIN SODIUM 122 112 13 17
CARVEDILOL 115 98 14 21
PRAVASTATIN SODIUM 109 109 15 15
POTASSIUM CHLORIDE 107 96 16 9
SERTRALINE HCL 105 96 17 23
ATORVASTATIN CALCIUM 100 91 18 13
KLOR-CON M20 94 93 19 76
HYDROCHLOROTHIAZIDE 88 64 20 12
TRAMADOL HCL 87 78 21 14
METFORMIN HCL 86 83 22 8
TAMSULOSIN HCL 80 73 23 32
ZOLPIDEM TARTRATE 80 52 23 16
POLYETHYLENE GLYCOL 3350 80 59 23 57
PAROXETINE HCL 73 68 26 52
CLOPIDOGREL 68 65 27 25
LEVETIRACETAM 67 49 28 110
ISOSORBIDE MONONITRATE ER 66 65 29 59
ESCITALOPRAM OXALATE 66 58 29 73
LANTUS 63 59 31 51
NOVOLOG 63 58 31 116
ADVAIR DISKUS 55 51 33 41
GABAPENTIN 55 42 33 10
TRAZODONE HCL 53 46 35 37
MIRTAZAPINE 53 53 35 64
METOPROLOL SUCCINATE 50 46 37 18
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Aug. 29, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.